期刊文献+

2015-2018年单中心739例慢性心力衰竭住院患者的临床特征分析 被引量:20

Analysis of clinical characteristics of 739 hospitalized patients with chronic heart failure admitted to a single center from 2015 to 2018
下载PDF
导出
摘要 目的了解山西医科大学第二临床医学院慢性心力衰竭住院患者的病因构成、合并症和诊疗特点,比较不同射血分数心力衰竭患者的基线资料。方法收集2015-01-01~2018-07-31于我院心血管内科住院的慢性心力衰竭患者739例,回顾性分析患者的一般临床资料。结果本研究纳入的患者中男性401例(54.3%),女性338例(45.7%)。年龄为23-99岁,平均(66.7±14.5)岁。心力衰竭病因主要为冠心病269例(36.4%),其次为扩张型心肌病147例(19.9%)、高血压性心脏病114例(15.4%)、风湿性心脏病83例(11.2%)和其他126例(17.1%)。住院期间利尿剂、血管紧张素转换酶抑制剂/血管紧张素-Ⅱ受体拮抗剂(ACEI/ARB)、β受体阻滞剂、洋地黄类、醛固酮受体拮抗剂、血管扩张剂、钙离子拮抗剂、正性肌力药物的使用率分别为86.7%,65.8%,66.8%,37.6%,76.5%,75.0%,28.1%,49.3%。739例心力衰竭患者中射血分数减少性心衰(HFrEF)248例(33.6%),射血分数中间值的心衰(HFmrEF)111例(15.0%),射血分数保留性心衰(HFpEF)380例(51.4%)。与HFrEF组相比,HFmrEF组入院时收缩压更高、住院时间更长(P<0.05),以高血压性心脏病、风湿性心脏病多见,多合并胸腔积液,住院期间钙离子拮抗剂的使用率高(P<0.0167)。与HFpEF组相比,HFmrEF组患者以男性、有吸烟史、年龄≤34岁、NYHAⅣ级、扩心病、合并胸腔积液所占比例较高,利尿剂、ACEI/ARB、β受体阻滞剂、醛固酮受体拮抗剂使用率高(P<0.0167),入院时舒张压更高、住院时间长,BNP水平更高(P<0.05)。结论慢性心力衰竭的病因主要为冠心病、扩张型心肌病、高血压性心脏病、风湿性心脏病及其他。我院慢性心衰住院患者的诊治基本贴合指南推荐。不同射血分数的心力衰竭患者在一般临床资料、合并症及治疗特点存在差异。 Objective To understand the etiology,the comorbidities,the characteristics of diagnosis and treatment of in-hospital patients with chronic heart failure,and to compare the baseline data of heart failure patients with different ejection fractions.Methods A total of 739 patients with chronic heart failure were collected in the Second Clinical Medical College of Shanxi Medical University.The clinical data of heart failure were retrospectively analyzed.Results There were 401(54.3%)males and 338(45.7%)females in this study.The age of patients averaged(66.7±14.5)years(23-99 years).The main causes of chronic heart failure were coronary heart disease(269 cases,36.4%),followed by dilated cardiomyopathy(147 cases,19.9%),hypertensive heart disease(114 cases,15.4%),rheumatic heart disease(83 cases,11.2%)and others(126 cases,17.1%).The proportion of in-hospital patients using diuretics,angiotensin converting enzyme-inhibitors/angiotensin receptor blockers(ACEI/ARB),β-blockers,digitalis,aldosterone receptor antagonists,vasodilators,calcium antagonists and positive inotropic drugs was 86.7%,65.8%,66.8%,37.6%,76.5%,75.0%,28.1%and 49.3%,respectively.In 739 patients with chronic heart failure,there were 248 cases(33.6%)of heart failure with reduced ejection fraction(HFrEF),111 cases(15.0%)of heart failure with mid-range ejection fraction(HFmrEF)and 380 cases(51.4%)of heart failure with preserved ejection fraction(HFpEF).Compared with HFrEF patients,the HFmrEF patients had higher systolic blood pressure and longer hospital stay(P<0.05),and higher usage rate of calcium antagonists(P<0.016 7),and hypertensive heart disease,rheumatic heart disease and combined with pleural effusion were common in the HFmrEF patients.Compared with the HFpEF patients,the HFmrEF patients had a higher proportion of men,smoking,age≤34 years,NYHAⅣ,dilated cardiomyopathy and combined with pleural effusion,and there was higher usage rate of diuretic,ACEI/ARB,β-blockers,and aldosterone receptor antagonists in HFmrEF group(P<0.016 7),and higher diastolic
作者 卫瑾婷 梁斌 杨慧宇 边云飞 杨志明 WEI Jinting;LIANG Bin;YANG Huiyu;BIAN Yunfei;YANG Zhiming(Department of Cardiology,Second Clinical Medical College of Shanxi Medical University,Taiyuan 030001,China)
出处 《山西医科大学学报》 CAS 2019年第6期702-708,共7页 Journal of Shanxi Medical University
关键词 慢性心力衰竭 住院患者 射血分数 回顾性分析 chronic heart failure inpatients ejection fraction retrospective analysis
  • 相关文献

参考文献16

二级参考文献83

  • 1鲁风云,李存效,崔耀刚,詹小娜,何志奇.充血性心力衰竭患者甲状腺激素辅助治疗40例[J].第四军医大学学报,2005,26(11):1055-1055. 被引量:9
  • 2曹雅旻,胡大一,吴彦,王宏宇.我国基层医院慢性心力衰竭主要原因的初步调查[J].中华内科杂志,2005,44(7):487-489. 被引量:29
  • 3张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 4张明,周聊生.老年人心功能不全与血浆B型尿钠肽水平的关系[J].山东医药,2005,45(34):41-41. 被引量:1
  • 5Djousse L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA, 2009, 302: 394-400. 被引量:1
  • 6Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 50-day mortality and readmission. Circ Cardiovasc Qual Outcomes, 2009, 2: 407-413. 被引量:1
  • 7Radford MJ, Arnold JM, Bennett SJ, et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards). Circulation, 2005, 112:1888-1916. 被引量:1
  • 8Sato N, Kajimoto K, Asai K, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J, 2010, 159: 949-955. 被引量:1
  • 9Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J, 2005, 149: 209-216. 被引量:1
  • 10Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J, 2006, 27: 2725-2736. 被引量:1

共引文献7187

同被引文献222

引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部